Search research articles
Contact Us
Filters
Showing results (331-340 of 337) with videos related to
Page
of 34
Sort By:
You have reached the last page of results.
This site can display upto 337 results.
Nature Communications
|
August 25, 2021
Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidatesfor targeted treatment
Hua Sun, Song Cao, R Jay Mashl, et al.
Cancer Research
|
July 31, 2024
A Pan-Cancer Patient-Derived Xenograft Histology Image Repository with Genomic and Pathologic Annotations Enables Deep Learning Analysis
Brian S White, Xing Yi Woo, Soner Koc, et al.
Nature Medicine
|
February 19, 2021
Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial
Tina Cascone, William N William, Annikka Weissferdt, et al.
Nature Genetics
|
January 8, 2021
Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts
Xing Yi Woo, Jessica Giordano, Anuj Srivastava, et al.
Nature
|
November 6, 2007
Characterizing the cancer genome in lung adenocarcinoma
Barbara A Weir, Michele S Woo, Gad Getz, et al.
Nature
|
October 25, 2008
Somatic mutations affect key pathways in lung adenocarcinoma
Li Ding, Gad Getz, David A Wheeler, et al.
Nature
|
October 9, 2024
CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors
Ferdinandos Skoulidis, Haniel A Araujo, Minh Truong Do, et al.
Page
of 34
Search research articles
Search
Showing results (331-340 of 337) with videos related to
Sort By:
Page
of 34
You have reached the last page of results.
This site can display upto 337 results.
Nature Communications
|
August 25, 2021
Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidatesfor targeted treatment
Hua Sun, Song Cao, R Jay Mashl, et al.
Cancer Research
|
July 31, 2024
A Pan-Cancer Patient-Derived Xenograft Histology Image Repository with Genomic and Pathologic Annotations Enables Deep Learning Analysis
Brian S White, Xing Yi Woo, Soner Koc, et al.
Nature Medicine
|
February 19, 2021
Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial
Tina Cascone, William N William, Annikka Weissferdt, et al.
Nature Genetics
|
January 8, 2021
Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts
Xing Yi Woo, Jessica Giordano, Anuj Srivastava, et al.
Nature
|
November 6, 2007
Characterizing the cancer genome in lung adenocarcinoma
Barbara A Weir, Michele S Woo, Gad Getz, et al.
Nature
|
October 25, 2008
Somatic mutations affect key pathways in lung adenocarcinoma
Li Ding, Gad Getz, David A Wheeler, et al.
Nature
|
October 9, 2024
CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors
Ferdinandos Skoulidis, Haniel A Araujo, Minh Truong Do, et al.
Page
of 34